MOORESVILLE, N.C., Feb. 8 /PRNewswire-FirstCall/ -- Anpath Group, Inc. (OTC Bulletin Board: ANPG), reported today that its wholly-owned subsidiary, EnviroSystems, Inc. (ESI) reported several advancements with the introduction of EquineTru(R). The Company earlier announced the introduction of an animal care product line with the market launch of EquineTru(R), an antiseptic treatment for skin and hoof conditions in horses, at the Atlanta Fall Classic Horse Show.
The Company recently reported that EquineTru(R) is one of this year's sponsors of the Winter Equestrian Festival, January 16-April 5, 2008, held in Wellington, FL. The festival is a Hunter/Jumper and Dressage event with over $3 million in prize money and expects to attract thousands of horses during the course of the show. Many of the world's leading competitors, including members of the US Olympic Equestrian Team, will participate in the festival.
"The initial reception of EquineTru(R) at the Winter Equestrian Festival has been very positive," commented J. Lloyd Breedlove, Anpath Group President & CEO. Mr. Breedlove added, "We expect EquineTru(R) to be accepted by leading riders, trainers, owners and veterinarians as a valuable tool in controlling difficult to treat skin and hoof conditions. Feedback from customers who have used EquineTru(R) confirms that the product is a great solution to these serious and expensive ailments and the word is quickly spreading beyond the boundaries of the show."
EquineTru(R) was developed to safely prevent and eliminate persistent and often debilitating skin and hoof ailments caused by micro-organisms. The active ingredient in EquineTru(R), Parachlorometaxylenol (PCMX) has been widely used as an antimicrobial in surgical hand and skin scrubs, antiseptics and disinfectants. It is also successfully used as a topical antiseptic for skin and mucous membranes, an antimicrobial in cosmetic formulations, and as a fungicide in a variety of applications. Further, its use is permitted for Unites States Equestrian Federation and Federation Equestre Internationale (FEI) regulated competitions. EquineTru(R) has been reviewed and cleared for market by the Center for Veterinary Medicine (CVM) a division of the U.S. Food and Drug Administration (FDA).
About Anpath Group, Incorporated:
Anpath Group, Inc., through its wholly-owned subsidiary EnviroSystems, Inc., produces cleaning and disinfecting products that it believes will help prevent the spread of infectious microorganisms while minimizing the harmful effects to people, equipment or the environment. Visit http://www.anpathgroup.com for more information.
EnviroSystems, Inc. is focused on safe infection prevention technologies that the company believes will position the company in the forefront of the industry at a time when there is rapidly growing awareness of the critical need to prevent biological risks -- both natural and man-made. For more information, please visit http://www.envirosi.com.
Forward Looking Statements:
This release contains forward-looking statements, which reflect expectation or belief by Anpath Group, Inc. concerning future events that involve risks and uncertainties. Anpath Group can give no assurance that the expectations reflected in forward looking statements will prove correct and various factors could cause results to differ materially from Anpath Group expectations, including, but not limited to EPA registration of the Company's products, the Company's ability to carry out its business plan, successful development and commercial acceptance of its products, ability to fund development of its technology, the risk that products may not result from development activities, protection of its intellectual property, need for regulatory approvals, and other factors discussed in periodic Anpath Group, Inc. filings with the Securities and Exchange Commission. Forward-looking statements are qualified in their entirety by the above cautionary statement. Anpath Group assumes no duty to update its outlook or other forward-looking statements as of any future date.
|SOURCE Anpath Group, Inc.|
Copyright©2008 PR Newswire.
All rights reserved